Human Osteopenic Bone‐Derived Osteoblasts: Essential Amino Acids Treatment Effects

References

• Bonewald L. F., Dallas S. L. Role of active and latent TGFbeta in bone formation. J. Cell Biochem. 1994; 55: 350–357
   PubMed Web of Science ®Google Scholar
• Bruder S. P., Kurth A., Shea M., Hayes W. C., Jaiswal N., Kadiyala S. Bone regeneration by implantation of purified culture‐expanded human mesenchymal stem cells. J. Orthop. Res. 1998; 16: 155–162
   PubMed Web of Science ®Google Scholar
• Centrella M., Horowitz M. C., Wozney J. M., McCarthy T. L. Transforming growth factor‐beta gene family members and bone. Endocr. Rev. 1994; 15: 26–39
   Web of Science ®Google Scholar
• Chevalley T. H., Rizzoli R., Manen D., Caverzasio J., Bonjour J. P. Arginine increases insulin‐like growth factor‐I production and collagen synthesis in osteoblast‐like cells. Bone 1998; 23(2)103–109
   PubMed Web of Science ®Google Scholar
• Clementi G., Fiore L. E., Mangano N. G., Catulli V. M., Pennisi P., Caruso A., Prato A., Matera M., Amico‐Roxas M. Role of soy diet and L‐arginine in cyclosporin‐A induced osteopenia in rats. Pharmacol. Toxicol. 2001; 88(1)16–19
   PubMedGoogle Scholar
• Conconi M. T., Tommasini M., Muratori E., Panigotto P. P. Essential aminoacids increase the growth and alkaline phosphatase activity in osteoblast cultured in vitro. Farmaco 2001; 56(10)755–761
   PubMedGoogle Scholar
• Fini M., Nicoli Aldini N., Canè V., Zaffe D., Giavaresi G., Rocca M., Guzzardella G. A., Giardino R. Effects of essential aminoacids and lactose on bony fractures and defects in rabbits. Arch. Orthop. Trauma Surg. 1999; 119: 39–45
   PubMed Web of Science ®Google Scholar
• Fini M., Torricelli P., Giavaresi G., Carpi A., Nicolini A., Giardino R. Effects of L‐Lysine and L‐Arginine on primary osteoblast cultures from normal and osteopenic rats. Biomed. Pharmacother. 2001; 55(4)213–220
   PubMed Web of Science ®Google Scholar
• Fiore C. E., Pennisi P., Cutuli V. M., Prato A., Messina R., Clementi G. L‐arginine prevents bone loss and bone collagen breakdown in cyclosporin A‐treated rats. Eur. J. Pharmacol. 2000; 408(3)323–326
   PubMed Web of Science ®Google Scholar
• Jilka R. L. Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. Bone 1998; 23(2)75–81
   PubMed Web of Science ®Google Scholar
• Kassem M., Kveiborg M., Eriksen E. F. Production and action of transforming growth factor‐beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Eur. J. Clin. Invest. 2000; 30(5)429–437
   PubMed Web of Science ®Google Scholar
• Katzburg S., Lieberherr M., Ornoy A., Klein B. Y., Hendel D., Somjen D. Isolation and hormonal responsiveness of primary cultures of human bone‐derived cells: gender and age differences. Bone 1999; 25(6)667–673
   PubMed Web of Science ®Google Scholar
• Lomri A., Marie P. J. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women. J. Bone Miner. Res. 1990; 5(11)1149–1155
   PubMed Web of Science ®Google Scholar
• Marie P. J. Cellular and molecular alterations of osteoblasts in human disorders of bone formation. Histol. Histopathol. 1999; 14: 525–538
   PubMed Web of Science ®Google Scholar
• Raisz L. G., Rodan G. A. Embriology and cellular biology of bone. Metabolic Bone Disease3rd Ed., L. V. Avioli, S. M. Krane. Academic Press. 1998; 15–16, chapter 1
   Google Scholar
• Sasse T., Becker P., Dorfling P., Schuhr T., Brock J. TGFbeta1 mRNA expression and proliferation of human osteoblastic cells in nonosteoporotic and osteoporotic women under influence of TGFbeta1 and IGF‐I. Calcif. Tissue Int. 1998; 62(2)140–147
   PubMed Web of Science ®Google Scholar
• Siggelkow H., Benzler K., Atkinson M. J., Hufener M. The use of confluence stages does not decrease the overall variability in primary human osteoblasts but can give additional information on differentiation in vitro. Exp. Clin. Endocrinol. Diabetes 1998; 106(3)217–225
   PubMed Web of Science ®Google Scholar
• Thavarajah M., Evans D. B., Kanis J. A. Differentiation of heterogeneous phenotypes in human osteoblast cultures in response to 1.25‐dihydroxyvitamin D3. Bone 1993; 14(5)763–767
   PubMed Web of Science ®Google Scholar
• Torricelli P., Fini M., Giavaresi G., Giardino R., Gnudi S. L‐arginine and L‐lysine stimulation on cultured human osteoblasts. Biomed. Pharmacother., In press
   Web of Science ®Google Scholar
• Torricelli P., Fini M., Rocca M., Giavaresi G., Giardino R. In vitro pathological model of osteopenia to test orthopaedic biomaterials. Art. Cells, Blood Subs., and Immob. Biotechnol. 2000; 28(2)181–192
   PubMed Web of Science ®Google Scholar
• Torricelli P., Fini M., Giavaresi G., Giardino R. Bone tissue cultures: an in vitro model for the evaluation of bone defect healing after L‐Arginine and L‐Lysine administration. Art. Cells, Blood Subs., and Immob. Biotechnol. 2001a; 29(4)325–334
   PubMed Web of Science ®Google Scholar
• Torricelli P., Verné E., Vitale Brovarone C., Appendino P., Rustichelli F., Krajewski A., Ravaglioli A., Pierini G., Fini M., Giavaresi G., Giardino R. Biological glass coating on ceramic materials: in vitro evaluation using primary osteoblast cultures from healthy and osteopenic rat bone. Biomaterials 2001b; 22(18)2535–2543
   PubMed Web of Science ®Google Scholar
• Tumber A., Meikle M. C., Hill P. A. Autocrine signals promote osteoblast survival in culture. J. Endocrinol. 2000; 167(3)383–390
   PubMed Web of Science ®Google Scholar
• Visser J. J., Hoekman K. Arginine supplementation in the prevention and treatment of osteoporosis. Med. Hypothesis 1994; 43: 339–342
   PubMed Web of Science ®Google Scholar
• Walsh C. A., Birch M. A., Fraser W. D., Ginty A. F., Gallagher J. A. Cytokines expression by cultured osteoblasts from patients wih osteoporotic fractures. Int. J. Exp. Pathol. 2000; 81(2)159–163
   PubMed Web of Science ®Google Scholar
• Wong M. M., Rao L. G., Ly H., Hamilton L., Ish‐Shalom S., Sturtridge W., Tong J., McBroom R., Josse R. G., Murray T. M. In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non‐osteoporotic controls. Osteoporosis Int. 1994; 4: 21–31
   PubMed Web of Science ®Google Scholar